Calithera Biosciences Analysis
Calithera Biosciences is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Calithera Biosciences pink sheet analysis is to determine its intrinsic value, which is an estimate of what Calithera Biosciences is worth, separate from its market price. There are two main types of Calithera Biosciences' stock analysis: fundamental analysis and technical analysis.
The Calithera Biosciences pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Calithera Biosciences' ongoing operational relationships across important fundamental and technical indicators.
Calithera |
Calithera Pink Sheet Analysis Notes
About 27.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.86. Some equities with similar Price to Book (P/B) outperform the market in the long run. Calithera Biosciences recorded a loss per share of 1.59. The entity had not issued any dividends in recent years. The firm had 1:20 split on the 15th of June 2022. Calithera Biosciences, Inc., a clinical-stage bio-pharmaceutical company, focuses on the discovery and development of small molecule compounds for tumor metabolism and tumor immunology targets for the treatment of cancer in the United States. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California. Calithera Biosci operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 63 people.The quote for Calithera Biosciences is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Calithera Biosciences please contact Susan Molineaux at 650 870-1000 or go to www.calithera.com.Calithera Biosciences Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more pink sheets at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Calithera Biosciences' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Calithera Biosciences or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Calithera Biosciences is not yet fully synchronised with the market data | |
| Calithera Biosciences has some characteristics of a very speculative penny stock | |
| Calithera Biosciences has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (39.65 M) with loss before overhead, payroll, taxes, and interest of (42.7 M). | |
| Calithera Biosciences currently holds about 41.79 M in cash with (43.61 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.59. |
Calithera Biosciences Upcoming and Recent Events
Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Calithera Biosciences previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 27th of November 2023 Upcoming Quarterly Report | View | |
| 30th of September 2023 Next Fiscal Quarter End | View |
Calithera Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 341.07 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Calithera Biosciences's market, we take the total number of its shares issued and multiply it by Calithera Biosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Calithera Biosciences Outstanding Bonds
Calithera Biosciences issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Calithera Biosciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Calithera bonds can be classified according to their maturity, which is the date when Calithera Biosciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Calithera Biosciences to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Equity Forecasting Now
Equity ForecastingUse basic forecasting models to generate price predictions and determine price momentum |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Consideration for investing in Calithera Pink Sheet
If you are still planning to invest in Calithera Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Calithera Biosciences' history and understand the potential risks before investing.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |